Open AccessTransdermal Fentanyl for Cancer Pain Management in Opioid-Naive Pediatric Cancer Patients
Author(s) -
Mohamed I. A. Othman,
Mohamad Farouk Mohamad,
Heba Sayed
Publication year - 2016
Publication title -
pain medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.893
H-Index - 97
eISSN - 1526-4637
pISSN - 1526-2375
DOI - 10.1093/pm/pnw004
Subject(s) - medicine , transdermal , fentanyl , cancer pain , opioid , cancer , anesthesia , pain management , pharmacology , receptor
Transdermal therapeutic system fentanyl with a drug release rate of 12 µg/h should be of special value in pediatric cancer pain control. Such a fentanyl formulation allows for a stepwise dose increase, similar to that reported for sustained-release morphine.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom